![Breaking News: Candel Therapeutics Plans to Raise $80 Million Through Public Offering in 2024](https://marketsgonewild.com/wp-content/uploads/2025/01/Breaking-News-Candel-Therapeutics-Plans-to-Raise-80-Million-Through-Public-Offering-in-2024-600x360.jpg)
Breaking News: Candel Therapeutics Plans to Raise $80 Million Through Public Offering in 2024
Candel Therapeutics Announces Public Offering What You Need to Know NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the launch of an underwritten public offering of $80 million of its common…